financetom
Business
financetom
/
Business
/
DraftKings Insider Sold Shares Worth $1,530,533, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DraftKings Insider Sold Shares Worth $1,530,533, According to a Recent SEC Filing
Nov 10, 2025 1:08 AM

03:49 AM EST, 11/10/2025 (MT Newswires) -- R Stanton Dodge, Chief Legal Officer, on November 06, 2025, sold 52,777 shares in DraftKings ( DKNG ) for $1,530,533. Following the Form 4 filing with the SEC, Dodge has control over a total of 500,454 Class A common shares of the company, with 500,454 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1883685/000140443025000011/xslF345X05/wk-form4_1762563060.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: IES Shares Fall After Reporting Fiscal Q1 Results
Update: IES Shares Fall After Reporting Fiscal Q1 Results
Mar 11, 2026
11:24 AM EST, 01/30/2026 (MT Newswires) -- (Updates with recent stock price movement in the headline and first paragraph.) IES (IESC) shares were down 19% in recent Friday trading after the company reported fiscal Q1 adjusted earnings of $3.71 per diluted share, up from $2.64 a year earlier. A single analyst polled by FactSet expected $3.94. Revenue for the quarter...
--Cincinnati Financial Increases Quarterly Dividend to $0.94 per Share From $0.87; Payable April 15 to Holders of Record March 24
--Cincinnati Financial Increases Quarterly Dividend to $0.94 per Share From $0.87; Payable April 15 to Holders of Record March 24
Mar 11, 2026
03:25 PM EST, 01/30/2026 (MT Newswires) -- Price: 160.06, Change: +1.87, Percent Change: +1.18 ...
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
Corcept Therapeutics (CORT) Shares Fall Again Amid Report FDA Warned Several Times Not to Submit Relacorilant Drug Application – Hagens Berman
Mar 11, 2026
SAN FRANCISCO, Jan. 30, 2026 (GLOBE NEWSWIRE) -- The latest adverse development for Corcept Therapeutics ( CORT ) concerning its proposed treatment of patients with hypercortisolism (also known as Cushing’s syndrome) – relacorilant – came on January 30, 2026 when Reuters reported that the FDA “warned the company ‘on several occasions’ not to submit its drug application.” This news sent...
Visa Delivers Fiscal Q1 Beat Despite Lower FX Volatility, Higher Marketing Spend, Oppenheimer Says
Visa Delivers Fiscal Q1 Beat Despite Lower FX Volatility, Higher Marketing Spend, Oppenheimer Says
Mar 11, 2026
11:22 AM EST, 01/30/2026 (MT Newswires) -- Visa (V) managed to deliver a fiscal Q1 beat even amid higher marketing spend and lower foreign exchange volatility, Oppenheimer said. Visa's operating expenses were slightly above expectations in the quarter. The investment firm said in a Thursday note that the company's Q2 operating expense growth guidance came in at the high end...
Copyright 2023-2026 - www.financetom.com All Rights Reserved